AISAP Cardio vs SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AISAP Cardio

by AISAP

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

AI Verdict

AISAP Cardio and SensiCardiac Mobi are adjacent AI tools in cardiac diagnostics, differing primarily in their input and specific focus. AISAP Cardio leverages ultrasound for comprehensive structural and functional cardiac assessments, including valvular pathologies and ejection fraction. In contrast, SensiCardiac Mobi analyzes acoustic heart signals from a stethoscope to assist in differentiating physiological from pathological heart murmurs.

Choose AISAP Cardio if…

Choose AISAP Cardio if your clinical setting requires rapid, comprehensive, AI-powered cardiac diagnostic assessments directly at the point of care using ultrasound. This tool is ideal for early detection and detailed evaluation of structural heart disease and heart failure, providing automated measurements of key cardiac parameters and generating full reports.

View AISAP Cardio →

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SensiCardiac Mobi if you need an AI-powered mobile solution to assist in the initial diagnosis and differentiation of heart murmurs using an electronic stethoscope. This application is best suited for physicians seeking to quickly analyze acoustic heart signals at the bedside, helping to distinguish between physiological and pathological murmurs as a decision support tool.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AISAP Cardio	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Pricing	Unknown	Contact for pricing
Deployment	Cloud-based	Hosted server environment (Linux OS) with a mobile application interface
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AISAP Cardio

AISAP Cardio offers a comprehensive, integrated workflow for point-of-care ultrasound (POCUS), automating complex cardiac measurements and interpretations, and integrating with existing EHR/EMR and PACS systems. While SensiCardiac Mobi is a mobile app, its reliance on a user-provided electronic stethoscope and specific recording procedures might introduce more steps compared to AISAP's broader, more automated POCUS workflow designed for ease of use by non-specialists.

Clinical Value

AISAP Cardio

AISAP Cardio provides a significantly broader and more quantitative diagnostic assessment, covering structural heart disease, heart failure, valvular pathologies, and detailed cardiac measurements like LVEF. SensiCardiac Mobi focuses specifically on differentiating physiological from pathological heart murmurs, which is valuable but narrower in scope. AISAP's ability to offer comprehensive cardiac assessments at the point of care provides greater overall clinical value for a wider range of cardiac conditions.

Pricing & Value

Tie

Neither AISAP Cardio nor SensiCardiac Mobi provides publicly available pricing information, both requiring direct contact for a demo and pricing details. Without any specific cost data or pricing models, it is impossible to conduct a meaningful comparison of their respective value propositions.

Enterprise Readiness

AISAP Cardio

Both tools are FDA-cleared and explicitly state HIPAA compliance, with SensiCardiac Mobi also confirming a BAA. However, AISAP Cardio's cloud-based SaaS platform, vendor-agnostic nature, and seamless integration with existing clinical workflows, EHR/EMR, and PACS systems suggest a more robust and scalable solution for large enterprise deployments.

Innovation

AISAP Cardio

Both tools are innovative in their applications of AI. AISAP Cardio's innovation lies in transforming POCUS into Point-of-Care Assisted Diagnosis (POCAD), making comprehensive, expert-grade cardiac assessments accessible to a wider range of clinicians and automating complex interpretations. This represents a significant advancement in democratizing advanced cardiac diagnostics. SensiCardiac Mobi's application of AI to heart murmur detection is valuable but a more focused enhancement of a traditional diagnostic method.

Support & Docs

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

SensiCardiac Mobi explicitly provides 'SensiCardiac Manuals & User Guides' and a user manual PDF, indicating readily available documentation for users. While AISAP Cardio mentions 'education tools' and 'training' for clinicians, specific documentation or a dedicated support portal was not readily found in the search results.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AISAP Cardio	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Name	AISAP Cardio	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Company	Aisap	DIACOUSTIC MEDICAL DEVICES (PTY)
Description Summary	FDA-cleared, AI-powered point-of-care ultrasound (POCUS) software platform that provides rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside.	FDA-cleared AI-powered mobile application that assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope to differentiate between physiological and pathological sounds.
Primary AI Function	AI-powered interpretation for early cardiac disease detection; automated generation of analyses, interpretations, and reports.	Analyzes heart sounds using the Sensi Diagnostic Heart Murmur Algorithm to distinguish between normal/physiological and pathological heart murmurs; identifies S1, S2, and suspected murmurs.
Key Cardiac Assessments	Assessment of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis); Measurement of Left Ventricle Ejection Fraction (LVEF); Measurement of right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter.	Diagnosing heart murmurs; differentiating between physiological and pathological heart murmurs.
Required Hardware/Integration	Vendor-agnostic and scalable solution; Integration with existing clinical workflows, EHR/EMR, and PACS.	Mobile application for data capture and display (e.g., iPhone 4S or later); Requires a compatible electronic stethoscope (user-provided).

Videos

Demos, reviews, and walkthroughs featuring AISAP Cardio and SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific clinical scenarios and patient populations are each tool best suited for, and how do they integrate into existing diagnostic workflows?

AISAP Cardio is designed for rapid, comprehensive cardiac diagnostic assessments using point-of-care ultrasound (POCUS), enabling early detection of structural heart disease and heart failure at the bedside. It is suitable for cardiology, emergency medicine, and radiology, integrating into existing clinical workflows by providing automated analyses, interpretations, and reports. SensiCardiac Mobi, conversely, is an AI-powered mobile application that assists in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope, differentiating between physiological and pathological sounds, and is best suited for cardiology, internal medicine, and pediatrics to complement physician auscultation.

How deeply does each tool integrate with existing EHR/EMR and PACS systems for data transfer and reporting?

AISAP Cardio offers seamless integration with existing clinical workflows, EHR/EMR, and PACS systems, allowing for automated generation and transfer of analyses, interpretations, and reports. SensiCardiac Mobi, while a mobile application for data capture and display, operates as decision support software and does not explicitly detail direct integration capabilities with EHR/EMR or PACS in the provided information, focusing more on its hosted server environment and mobile interface for data handling.

How do the AI algorithms of each tool contribute to the accuracy and sensitivity of cardiac assessments, particularly in differentiating between various cardiac conditions?

AISAP Cardio's AI-powered interpretation provides comprehensive cardiac diagnostic assessments and measurements for early detection of structural heart disease and heart failure, including valvular pathologies and ventricular dimensions, with studies indicating high sensitivity and specificity for significant major valve diseases. SensiCardiac Mobi's Sensi Diagnostic Heart Murmur Algorithm analyzes acoustic heart signals to distinguish between normal/physiological and pathological heart murmurs, identifying S1, S2, and suspected murmurs to assist physicians in diagnosis.

What is the expected learning curve for physicians and their teams to effectively utilize each tool, and what is the typical time-to-value for incorporating them into practice?

AISAP Cardio aims to empower clinicians with basic scanning skills to accurately diagnose common cardiac parameters within minutes, suggesting a relatively short learning curve for its comprehensive POCUS software, leading to rapid time-to-value through quick and accurate bedside assessments. SensiCardiac Mobi, being a mobile application that uses an electronic stethoscope for heart sound analysis, likely has a straightforward learning curve, as it guides users through the auscultation process and provides real-time analysis, facilitating quick integration into existing auscultation practices.

What are the key considerations for deploying each tool across multiple clinical sites or a large healthcare system?

AISAP Cardio is described as a vendor-agnostic and scalable solution, delivered as a cloud-based SaaS platform, which suggests ease of deployment and management across multiple sites due to its flexible architecture and integration capabilities. SensiCardiac Mobi operates from a hosted server environment with a mobile application interface, implying that multi-site deployment would involve managing the hosted server and ensuring mobile device compatibility and distribution across different locations.

What audit-trail features are available in each tool to track user actions, data modifications, and AI-generated interpretations for clinical governance and accountability?

AISAP Cardio automatically generates analyses, interpretations, and reports, which inherently provides a record of the AI's output and can be integrated into EHR/EMR systems for a comprehensive audit trail of diagnostic assessments. SensiCardiac Mobi acquires and records acoustic heart signals and provides detailed cardiac reports that visualize heart recordings and classifications, offering a documented record of the auscultation and AI-powered murmur detection for accountability.